Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, specifically related to the company's financial disclosures and performance claims [1][2]. Group 1: Company Background - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 [3]. Group 2: Allegations and Financial Performance - The lawsuit alleges that Fortrea overstated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp, as well as the revenue from pre-spin projects [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as claimed, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full year 2024 results, revealing lower-than-expected revenue and profitability from pre-spin projects, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

There’s a chance the Singapore dollar will strengthen to parity against its US counterpart in the next five years, according to Jefferies https://t.co/VDpy6SYTQp ...

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, stemming from allegations of overstating cost savings and revenue projections related to transition services agreements following its spin-off from Labcorp [1][2][4]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 [3]. Allegations and Financial Impact - The lawsuit claims that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp, as well as the revenue from pre-spin projects [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and full year 2024, stating that pre-spin projects had lower revenue and profitability than expected, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

[Financial Information](index=2&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This section provides a comprehensive overview of the company's financial performance and position, including detailed statements, management's analysis, and risk disclosures [Financial Statements](index=2&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for the quarterly period ended May 31, 2025, including statements of financial condition, earnings, comprehensive income, changes in equity, and cash flows, along with detailed notes Consolidated Financial Condition Highlights (Unaudited) | Indicator | May 31, 2025 | November 30, 2024 | | :--- | :--- | :--- | | **Total Assets** | $67,285.3 million | $64,360.3 million | | **Total Liabilities** | $56,902.8 million | $54,134.9 million | | **Total Equity** | $10,382.2 million | $10,225.0 million | Consolidated Earnings Highlights (Unaudited) | Metric ($ in thousands, except per share) | Three Months Ended May 31, 2025 | Three Months Ended May 31, 2024 | Six Months Ended May 31, 2025 | Six Months Ended May 31, 2024 | | :--- | :--- | :--- | :--- | :--- | | **Net Revenues** | $1,634,447 | $1,656,445 | $3,227,466 | $3,394,648 | | **Net Earnings** | $91,395 | $154,687 | $228,244 | $311,079 | | **Net Earnings Attributable to Common Shareholders** | $88,017 | $145,736 | $215,955 | $295,377 | | **Diluted EPS** | $0.40 | $0.64 | $0.97 | $1.31 | Consolidated Cash Flow Highlights (Unaudited, Six Months Ended May 31) | Cash Flow Activity ($ in thousands) | 2025 | 2024 | | :--- | :--- | :--- | | **Net Cash Used in Operating Activities** | $(3,643,497) | $(1,180,047) | | **Net Cash Used in Investing Activities** | $(157,144) | $(110,455) | | **Net Cash Provided by Financing Activities** | $2,885,268 | $3,499,293 | [Notes to Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) The notes provide detailed disclosures on significant accounting policies, business activities, and specific financial statement items, including segments, fair value, derivatives, and joint ventures - The company operates in two reportable business segments: **Investment Banking and Capital Markets** and **Asset Management**[25](index=25&type=chunk) - In February 2024, OpNet, a consolidated subsidiary, agreed to sell substantially all of its wholesale operating assets, with the sale closing in August 2024; the sale of Foursight Capital LLC closed in the second quarter of 2024[26](index=26&type=chunk)[42](index=42&type=chunk)[45](index=45&type=chunk) Level 3 Financial Instruments Roll-forward (Six Months Ended May 31, 2025, $ in thousands) | Category | Balance at Nov 30, 2024 | Net Gains/Losses | Purchases/Issuances | Sales/Settlements | Net Transfers | Balance at May 31, 2025 | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Total Level 3 Assets** | $734,225 | $2,503 | $218,344 | $(142,559) | $(57,200) | $763,039 | | **Total Level 3 Liabilities** | $866,006 | $(36,343) | $240,243 | $(164,225) | $(36,512) | $1,049,169 | - The company has significant equity method investments in Jefferies Finance (50/50 joint venture with MassMutual) and Berkadia (joint venture with Berkshire Hathaway), with investment balances of **$663.5 million** and **$437.7 million** respectively as of May 31, 2025[151](index=151&type=chunk)[154](index=154&type=chunk)[157](index=157&type=chunk) Segment Performance (Six Months Ended May 31, $ in millions) | Segment | Net Revenues 2025 | Net Revenues 2024 | Pre-Tax Earnings 2025 | Pre-Tax Earnings 2024 | | :--- | :--- | :--- | :--- | :--- | | **Investment Banking & Capital Markets** | $2,869.4 | $2,945.7 | $355.1 | $406.3 | | **Asset Management** | $346.3 | $429.9 | $(80.9) | $22.6 | - The company maintains a strategic alliance with Sumitomo Mitsui Banking Corporation (SMBC), which owns approximately **15.7%** of the company's common stock on an as-converted basis as of May 31, 2025[220](index=220&type=chunk)[262](index=262&type=chunk) [Management's Discussion and Analysis (MD&A)](index=45&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management provides an analysis of the company's financial performance for the second quarter and first half of 2025, covering consolidated results, revenue and expense analysis, liquidity, capital resources, and risk management practices [Consolidated Results of Operations](index=41&type=section&id=2.1%20Consolidated%20Results%20of%20Operations) For the six months ended May 31, 2025, net revenues decreased by 4.9% to $3.23 billion, and earnings from continuing operations before taxes fell 36.2% to $286.0 million, primarily due to lower Fixed Income and Asset Management results and higher non-compensation expenses Financial Performance vs. Prior Year | Metric ($ in thousands) | Six Months Ended May 31, 2025 | Six Months Ended May 31, 2024 | % Change | | :--- | :--- | :--- | :--- | | **Net Revenues** | $3,227,466 | $3,394,648 | (4.9)% | | **Earnings from Continuing Operations Before Income Taxes** | $285,966 | $447,996 | (36.2)% | | **Net Earnings Attributable to Common Shareholders** | $215,955 | $295,377 | (26.9)% | - The decrease in profitability was attributed to market uncertainty from U.S. policy and geopolitical events, a decline in investment returns from the Asset Management business, reduced performance in the Fixed Income business, and higher non-compensation expenses[280](index=280&type=chunk) [Revenues by Source](index=43&type=section&id=2.2%20Revenues%20by%20Source) For the six months ended May 31, 2025, Investment Banking advisory revenues grew 37.5% and Equities revenues increased 17.7%, but these gains were offset by declines in Fixed Income and Asset Management revenues Net Revenues by Business Line (Six Months Ended May 31, $ in millions) | Business Line | 2025 | 2024 | % Change | | :--- | :--- | :--- | :--- | | **Investment Banking** | $1,467.0 | $1,514.4 | (3.1)% | | *Advisory* | *$855.6* | *$622.5* | *37.5%* | | *Underwriting (Equity & Debt)* | *$655.6* | *$793.2* | *(17.3)%* | | **Equities** | $935.3 | $794.7 | 17.7% | | **Fixed Income** | $467.1 | $636.7 | (26.6)% | | **Asset Management** | $346.3 | $429.9 | (19.4)% | - The investment banking backlog remains strong, but the timing of its realization is uncertain due to ongoing U.S. policy and geopolitical events[295](index=295&type=chunk) - Aggregate net assets under management (AUM) increased to **$31.4 billion** as of May 31, 2025, from **$28.0 billion** at November 30, 2024[317](index=317&type=chunk) [Non-interest Expenses](index=50&type=section&id=2.3%20Non-interest%20Expenses) For the six months ended May 31, 2025, total non-interest expenses were flat at $2.94 billion, with compensation and benefits decreasing 5.2% while non-compensation expenses rose due to higher business development, brokerage fees, and technology costs Non-interest Expenses (Six Months Ended May 31, $ in thousands) | Expense Category | 2025 | 2024 | % Change | | :--- | :--- | :--- | :--- | | **Compensation and benefits** | $1,695,966 | $1,788,864 | (5.2)% | | **Brokerage and clearing fees** | $239,181 | $220,206 | 8.6% | | **Business development** | $152,361 | $126,281 | 20.7% | | **Technology and communications** | $285,673 | $272,750 | 4.7% | | **Other** | $157,034 | $125,417 | 25.2% | | **Total non-interest expenses** | $2,941,500 | $2,946,652 | (0.2)% | - The compensation and benefits expense as a percentage of net revenues was **52.5%** for the first half of 2025, compared to **52.7%** for the same period in 2024[323](index=323&type=chunk) [Liquidity, Financial Condition and Capital Resources](index=53&type=section&id=2.4%20Liquidity,%20Financial%20Condition%20and%20Capital%20Resources) The company maintains a robust liquidity and capital position, with total long-term capital of $21.8 billion and a leverage ratio of 6.5x as of May 31, 2025, returning $244.7 million to shareholders while increasing long-term debt Key Financial Ratios and Balances | Metric | May 31, 2025 | November 30, 2024 | | :--- | :--- | :--- | | **Total Assets** | $67,285 million | $64,360 million | | **Total Equity** | $10,382 million | $10,225 million | | **Tangible Shareholders' Equity** | $8,245 million | $8,103 million | | **Leverage Ratio** | 6.5x | 6.3x | | **Tangible Gross Leverage Ratio** | 7.9x | 7.7x | - Total long-term capital stood at **$21.76 billion** at May 31, 2025, with a long-term debt to equity capital ratio of **1.10:1**[389](index=389&type=chunk)[390](index=390&type=chunk) - The company's liquidity management framework includes a Cash Capital Policy, a Modeled Liquidity Outflow (MLO) assessment, and a Contingency Funding Plan (CFP) to ensure sufficient liquidity in stressed conditions[371](index=371&type=chunk) - During the six months ended May 31, 2025, the company returned **$244.7 million** to shareholders, consisting of **$187.1 million** in dividends and **$57.6 million** in share repurchases for tax withholding[358](index=358&type=chunk) [Risk Management](index=60&type=section&id=2.5%20Risk%20Management) The company employs a comprehensive risk management framework to address market, credit, operational, and other principal risks, with average daily firmwide VaR decreasing to $11.89 million in Q2 2025 - Principal risks are identified as market, credit, liquidity and capital, operational, model, strategic, legal, compliance, new business, and reputational risk[418](index=418&type=chunk) Daily Firmwide VaR (95%, 1-day, for Q2 2025) | Metric ($ in millions) | Value | | :--- | :--- | | **VaR at May 31, 2025** | $11.68 | | **Average** | $11.89 | | **High** | $15.39 | | **Low** | $8.96 | - Total counterparty credit exposure (excluding cash) was **$2.70 billion** at May 31, 2025, with the largest exposures to A-rated and BBB-rated counterparties[460](index=460&type=chunk) - The top non-U.S. country risk exposures (net issuer and counterparty risk, excluding cash) as of May 31, 2025, were to the **United Kingdom ($627.5M)**, **Canada ($471.0M)**, and **France ($142.9M)**[465](index=465&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=68&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section cross-references the market risk disclosures provided within the "Risk Management" section of Management's Discussion and Analysis (Item 2) - Quantitative and qualitative disclosures about market risk are set forth under "Management's Discussion and Analysis of Financial Condition and Results of Operations —Risk Management" in Part I, Item 2 of this Form 10-Q[470](index=470&type=chunk) [Controls and Procedures](index=68&type=section&id=Item%204.%20Controls%20and%20Procedures) Based on an evaluation as of May 31, 2025, the CEO and CFO concluded that the company's disclosure controls and procedures are effective, with no material changes to internal control over financial reporting during the quarter - Management, including the CEO and CFO, evaluated and concluded that the company's disclosure controls and procedures were effective as of May 31, 2025[471](index=471&type=chunk)[476](index=476&type=chunk) - No changes in internal control over financial reporting occurred during the quarter that materially affected, or are reasonably likely to materially affect, internal controls[477](index=477&type=chunk) [Other Information](index=69&type=section&id=PART%20II.%20OTHER%20INFORMATION) This section provides additional information on legal proceedings, risk factors, and equity security transactions [Legal Proceedings, Risk Factors, and Share Repurchases](index=69&type=section&id=Item%201.%20Legal%20Proceedings%20%26%20Item%201A.%20Risk%20Factors%20%26%20Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section covers legal matters, risk factors, and equity security transactions, noting routine legal proceedings, a specific litigation loss, consistent risk factors, and share repurchases for tax liabilities - The company is involved in various legal and regulatory matters in the normal course of business, which are not expected to have a material adverse effect on its financial statements[479](index=479&type=chunk) - A specific litigation against the former portfolio manager of 3|5|2 Capital ABS Master Fund LP resulted in a recognized loss of **$17.2 million** to date, with the outcome and potential recovery uncertain[480](index=480&type=chunk)[484](index=484&type=chunk) - There are no new risk factors reported; the company refers to the disclosures in its Annual Report on Form 10-K for the year ended November 30, 2024[485](index=485&type=chunk) Issuer Purchases of Equity Securities (Q2 2025) | Period | Total Shares Purchased | Average Price Paid per Share | Publicly Announced Program Purchases | Remaining Authorization | | :--- | :--- | :--- | :--- | :--- | | **Mar 2025** | 20,846 | $56.45 | — | $250.0M | | **Apr 2025** | — | — | — | $250.0M | | **May 2025** | 1,549 | $46.59 | — | $250.0M | | **Total** | **22,395** | **$55.77** | **—** | **$250.0M** |

Federal Reserve Leadership & Monetary Policy - The market is closely watching potential candidates to succeed Jerome Powell as Fed chair, including Hasset and Fed Governor Kevin Warsh [1][2][3] - The candidates are generally viewed as having similar thoughts on monetary policy, potentially limiting market impact [3] - The President believes rates are 3 percentage points too high [4] Monetary Policy Stance - The market views current monetary policy as restrictive, considering the balance sheet size relative to the economy's size pre-COVID [5][6] - The Fed funds rate was 100 basis points higher when the Fed previously cut rates [6] - PCE inflation was down 0.5 percentage points and unemployment was up 0.5 percentage points during the prior rate cut [7] Potential Rate Cut Controversy - A prior 50 basis point rate cut was perceived by some as being too close to the election [8][9] - A 25 basis point cut was considered more appropriate by some [8][9] - Candidates need a cogent reason for lowering rates, potentially using the balance sheet as justification [11] - Kevin Warsh has suggested using the balance sheet to push for lower rates [11]

A former Jefferies wealth adviser in Miami, one of a group that the Wall Street bank ousted last year after discovering a series of alleged misdeeds, was banned from the industry amid a regulatory probe. https://t.co/xdH33yMghK ...

Core Viewpoint - The announcement of tariffs is seen as a negative signal for emerging market arbitrage trades, particularly affecting currencies in Colombia, Brazil, and Chile, which have all depreciated by over 1.2% [1] Group 1 - Mark McCormick, the head of foreign exchange strategy at TD Securities, indicates that the tariff announcement is not favorable for overbought emerging market arbitrage trades [1] - Currencies in Colombia, Brazil, and Chile have experienced a decline of more than 1.2% following the tariff news [1] Group 2 - Brad Bechtel, global head of foreign exchange at Jefferies, suggests that the current situation remains uncertain and that Trump's letters may be aimed at facilitating a new round of negotiations [1] - Bechtel anticipates further announcements related to tariffs in the coming weeks [1]

Summary of Key Points from the Conference Call Industry or Company Involved - The discussion revolves around the implications of the One, Big, Beautiful Bill (OBBB) on macroeconomic factors and the energy transition in the United States. Core Points and Arguments Macro Implications 1. **Tax Regime Changes**: OBBB permanently extends lower individual tax rates from the 2017 Tax Cuts & Jobs Act (TCJA) and introduces significant business tax cuts, including immediate expensing of domestic R&D, which could benefit sectors like biotech, healthcare, and energy [2][3] 2. **Federal Debt Projections**: The Congressional Budget Office (CBO) projects federal debt to rise from 100% of GDP today to 118% by 2035, with annual deficits averaging 5.8% of GDP. The bill is estimated to add over $3 trillion to the deficit [3][4] 3. **Fiscal Cost Assessment**: The "current policy" baseline used by Senate Republicans may mask the true fiscal cost of OBBB, potentially leading to a smaller apparent deficit impact [4] 4. **Removal of Section 899**: The removal of Section 899, which proposed a retaliatory tax on passive income from US assets, is seen as a positive for US firms, potentially stabilizing investor sentiment [5] Social and Political Dynamics 5. **Populist Appeal vs. Social Spending Cuts**: While OBBB is marketed as a populist bill, critics argue that cuts to Medicaid and SNAP could harm working families, creating a tension that may benefit Democrats in future elections [10] 6. **Elon Musk's Political Influence**: Elon Musk is emerging as a disruptive political force, potentially challenging GOP senators who support OBBB and advocating for a new political party [11] Medicaid and State Budget Implications 7. **Medicaid Cuts**: OBBB includes $930 billion in cuts to Medicaid, Medicare, and the Affordable Care Act, which could restrict states' budget flexibility and force them to cut services or raise taxes [12] Energy Transition Implications 8. **Differentiation in Energy Tax Credits**: The bill treats different energy generation sources differently regarding tax credits, with nuclear and geothermal projects receiving favorable treatment compared to wind and solar [15] 9. **Foreign Entity of Concern (FEOC) Rules**: New clean generation projects must comply with FEOC rules to qualify for tax credits, aiming to reduce reliance on Chinese goods in the clean energy supply chain [17] 10. **Support for Carbon Management**: The 45Q tax credit for carbon capture remains intact, which is seen as a positive for carbon capture and removal projects [18] 11. **Permitting Challenges**: The removal of permitting changes from OBBB highlights ongoing bottlenecks in the energy transition process, with expectations for a standalone bill to address these issues [19] 12. **Consumer Spending on Clean Energy**: The withdrawal of consumer-facing credits may challenge retail spending in clean energy investments, particularly in the electric vehicle market [20] Corporate Tax Changes 13. **Lower Corporate Alternative Minimum Tax**: The final version of OBBB includes exceptions for domestic oil and gas companies regarding the 15% tax floor introduced by Biden's IRA [21] Other Important but Overlooked Content - The bill's provisions for student loan repayment and immigration changes could reshape labor dynamics and educational enrollment, potentially impacting the workforce in the long term [14] This summary encapsulates the key points discussed in the conference call regarding the implications of the OBBB on various sectors and the broader economic landscape.

Core Viewpoint - Palantir Technologies has shown significant stock performance, with a year-to-date increase of 70% or more, but most analysts on Wall Street are pessimistic about its future momentum, contrasting with a more optimistic outlook from Wedbush's Dan Ives [1][2][3]. Group 1: Analyst Sentiment - A survey of 25 analysts revealed that 6 rated Palantir as a sell or underperform, while 15 recommended holding the stock, leaving only 4 with favorable views [2]. - The average 12-month price target for Palantir is over 23% below its current share price, with RBC Capital predicting a nearly 70% drop to $40 per share [3]. - Concerns about Palantir's growth prospects are prevalent, despite the company expecting a revenue increase of approximately 36% in 2025, which is slower than its growth in the first quarter of 2025 [4]. Group 2: Valuation Concerns - Palantir's shares are trading at 238 times forward earnings, and its price/earnings-to-growth (PEG) ratio is 4.18, indicating a potentially unjustifiable valuation [5]. - Jefferies analyst Brent Thill noted a lack of institutional interest in Palantir due to its valuation, suggesting that retail investors are driving the stock's gains [14]. Group 3: Optimistic Outlook from Wedbush - Wedbush maintains an outperform rating for Palantir, with a 12-month price target of $140, reflecting a potential upside of 13.5% [6]. - Dan Ives believes Palantir's market cap could reach $1 trillion within the next two to three years, which would be more than three times its current market cap [7]. - Ives views Palantir as a leader in the AI software market, likening it to "the Messi of AI," and estimates that around $2 trillion will be spent on AI software in the coming years, with Palantir poised to capture a significant share of this growth [9][10].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, stemming from allegations of overstating cost savings and revenue projections related to transition services agreements following its spin-off from Labcorp [1][2][4]. Group 1: Company Background - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions [3]. - The company was spun off from Labcorp Holdings Inc. in June 2023, becoming a standalone publicly traded entity [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full-year 2024 financial results, revealing lower-than-expected revenue and profitability from pre-spin projects, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].